Considering the metabolic benefits of “beige/brite (brown-in-white) fat” formation [4], [5], irisin administration has been proposed as a potential therapeutic tool to treat obesity and diabetes [6] and thus may have implications for decreasing cardiovascular risk. This evidence concerns the gene FNDC5 and obesity disorder.